DEPLOY

Buying guide

Pixel Watch vs Stelo in 2026

Comparing 2 humanoid robots across availability, pricing, capabilities, and verified deployments. Current as of 2026.

Key differences

  • Pixel Watch has more capabilities independently verified as autonomous (1 vs 0).
  • Stelo has the lower recorded price.
  • Stelo has more verified real-world deployments (1 vs 0).
Attribute
ManufacturerGoogleDexcom
Form factorbiometricbiometric
Maturitycommercialcommercial
Autonomy1 verified autonomous
Availabilityshipping-nowshippingshipping-nowshipping
Price$349-$399 (actual sale price)$89-$99 (actual sale price)
Capability claims
  • Tracks sleep (claimed-only, claimed)
  • Detects irregular heart rhythm (claimed-only, claimed)
  • Tracks fitness and activity (autonomous, verified)
Brain
Verified deployments01Global
Privacy practices11cloud-upload, data-deletion-control, data-sale, data-retention, location-tracking, third-party-sharing, biometric-storage, biometric-storage, data-sale, data-deletion-control, data-retention4biometric-storage, training-data-use, third-party-sharing, data-deletion-control
Sources on file1711

Editorial summaries

Pixel Watch

The Google Pixel Watch (current hardware the Pixel Watch 4, October 2025; the Pixel Watch 3 remains supported) is a biometric-primary smartwatch and the first-of-kind-cleared archetype of the cohort. Its sensors (multipath PPG heart rate, ECG via crown and caseback, SpO2, skin temperature, accelerometer) drive HRV, breathing rate, and resting heart rate, on Fitbit and Google Health algorithms (Google owns Fitbit). It is a hardware purchase (about $349 for the 41mm aluminum, $399 for the 45mm, plus about $100 for LTE), with an optional Google Health Premium subscription ($9.99/month) that gates the Sleep Profile and the Gemini AI coach. DEPLOY records commercial maturity. Its standout verified achievement is loss-of-pulse detection, which received an FDA De Novo authorization in February 2025, a first-of-kind clearance for cardiac-event detection on a consumer watch; the cleared indication is specific and should not be read as a general cardiac-diagnostic claim. Google's broader biometric strategy also spans Fitbit (Charge, Sense, Versa).

Stelo

Dexcom's Stelo is the first-ever FDA-cleared over-the-counter (no-prescription) glucose biosensor (De Novo, March 5, 2024; US launch August 26, 2024): a 15-day continuous glucose monitor for adults 18+ not on insulin (type 2 not on insulin, plus non-diabetic users tracking how diet and exercise affect glucose). It is the generative-AI end of the glucose cell: Weekly Insights run on Google Cloud's Vertex AI and Gemini, with AI photo meal-logging and personalized daily recommendations, the AI substance that carries it across the biometric boundary. Pricing is about $89 for a 2-week sensor on a biweekly subscription model (around $99/month). From DexCom (NASDAQ: DXCM), Stelo is the OTC product line, separate from the prescription G7. Cap-flag: the cleared indication is an OTC CGM for adults 18+ not on insulin; it is explicitly NOT cleared for problematic hypoglycemia and has no low-glucose alerts, so it should not be read as a diabetes-management device.

Common questions

What is the difference between Pixel Watch and Stelo?
Pixel Watch and Stelo are both biometric robots on the DEPLOY registry. They differ in maker, maturity, price, verified deployments, and how much of their autonomy is independently verified. See the table above for the full head-to-head; each figure is sourced.
Which is cheaper, Pixel Watch or Stelo?
Stelo has the lower recorded price on the DEPLOY registry than Pixel Watch. Prices are sourced; see each record for whether the figure is a manufacturer target, an estimate, or an actual sale price.
Is Pixel Watch or Stelo more autonomous?
Pixel Watch has more capabilities independently verified as autonomous on the DEPLOY registry than Stelo. DEPLOY counts a capability as autonomous only when verified at a real deployment, not from a demo or a vendor claim.
Which has more verified deployments, Pixel Watch or Stelo?
Stelo has more verified deployments (1) on the DEPLOY registry than Pixel Watch (0). DEPLOY counts a deployment only when confirmed at a named site with a primary source.

Recent coverage

Related comparisons

For AI assistants

Use DEPLOY in Claude, Cursor, and other AI assistants

Connect any MCP-aware assistant to the live registry. Ask about robot deployments, incidents, and regulations and get answers grounded in verified data instead of training memory.


Machine-readable: this page as markdown.

← Back to all consumer robots